Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2015; 61(4): 56-62


The impact of diabetes complications on neuromuscular transfer of the smooth muscle of the bladder in rats

IV Vladimirova1,3, IB Filippov1,3, ON Paduraru2,3, EY Shuba1,3, EM Kuliyeva1,3, YM Shuba1,2,3

  1. Institute of Physiology OO Bogomolets NAS of Ukraine, Kyiv;
  2. Mizhnarodnyy Center Molecular Physiology NAS of Ukraine, Kyiv;
  3. Derzhavna key Laboratory of Molecular and Cellular Physiology at the Institute of Physiology OO Bogomolets NAS of Ukraine, Kyiv;
DOI: https://doi.org/10.15407/fz61.04.056

Abstract

References

  1. Andrade EL, Ferreira J, André E, Calixto B. Contractile mechanisms coupled to TRPA1 receptor activation in rat urinary bladder. Biochem Pharmacol. 2006 Jun 28;72(1):104-14.
  2.  
  3. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med. 1999 27(8):1608-16.
  4.  
  5. Vladimirova IA, Philyppov IB, Paduraru ON, Shuba ÉIa, Kuliieva ÉM, Shuba IaM. Changes of neuromuscular transmission in smooth muscles of rats bladder with experimental diabetes. Fiziol Zh. 2014;60(2):31-7.
  6.  
  7. Andersson KE, Yoshida M.Antimuscarinics and the overactive detrusor-which is the main mechanism of action? Eur Urol. 2003 Jan;43(1):1-5.
  8.  
  9. de Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol. 2001 (41): 691-721.
  10.  
  11. Hegde SS, Eglen RM. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci. 1999 64 (6-7): 419-28.
  12.  
  13. Latifpour J, Gousse A, Kondo S, Morita T, Weiss RM. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J Pharmacol Exp Ther.1989 248(1): 81-88.
  14.  
  15. Liu G1, Daneshgari F. Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol. 2005 Jun;288(6):F1220-6.
  16.  
  17. Luheshi GN, Zar MA. The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol. 1991 Jul;103(3):1657-62.
  18.  
  19. Mumtaz FH, Lau D.H, Siddiqui EJ, Morgan RJ, Thompson CS, Mikhailidis D.P. Changes in cholinergic and purinergic neurotransmission in the diabetic rabbit bladder. In Vivo. 2006 20 (1): 1-4.
  20.  
  21. Morrow TJ. Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci. 2004 Nov; Chapter 9:Unit 9.18.
  22.  
  23. Firouz Daneshgari, Guiming Liu and Peter B. Imrey. Time Dependent Changes in Diabetic Cystopathy in Rats Include Compensated and Decompensated Bladder Function. J. Urol. 2006, July 176: 380-86.
  24.  
  25. Juszczak K, Gil K, Wyczolkowski M, Thor PJ. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment. J Physiol Pharmacol. 2010 Aug;61(4):477-82.
  26.  
  27. Filippov I. B., Shuba M. F., T. L. Davydovskaya, L. S. Kholodnaya, Pozur B.B. Effects of active substances fromStaphylococcus aureus(protein a and peptidoglycan) on neurotransmitter-induced contractions of smooth muscles. Neurophysiology. 1996; January - November 28(4): 23239.
  28.  
  29. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005 Jul;18(3):521-40.
  30.  
  31. Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol. Toxicol.2007 23(5):303-12.
  32.  
  33. McDonald C1, Inohara N, Nu-ez G. Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem. 2005 May 27;280(21):20177-80.
  34.  
  35. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med. 1995 182(6):1673-82.
  36.  
  37. Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int. 2008 Mar;101 Suppl 3:2-6.
  38.  
  39. Skryma R, Prevarskaya N, Gkika D, Shuba Y. From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol. 2011 8(11): 617-30.
  40.  
  41. Lapointe TK, Altier C. The role of TRPA1 in visceral inflammation and pain. Channels (Austin). 2011 5 (6): 525-29.
  42.  
  43. Moilanen LJ, Laavola M, Kukkonen M, Korhonen R, Leppänen T, Högestätt ED, Zygmunt PM, Nieminen RM, Moilanen E. TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse. Sci Rep. 2012 2: 380.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.